Search Results - "нежелательные эффекты"

1

Academic Journal

Небажані ефекти базисної терапії у дітей, хворих на алергічну бронхіальну астму

Authors: Dudnyk, V.M., Khromykh, K.V.

Source: Zdorovʹe Rebenka, Vol 10, Iss 3.63, Pp 35-40 (2015)
CHILD`S HEALTH; № 3.63 (2015); 35-40
Здоровье ребенка-Zdorovʹe rebenka; № 3.63 (2015); 35-40
Здоров'я дитини-Zdorovʹe rebenka; № 3.63 (2015); 35-40

Subject Terms: children, bronchial asthma, endothelial dysfunction, adverse effects of treatment, діти, бронхіальна астма, ендотеліальна дисфункція, небажані ефекти лікування, дети, бронхиальная астма, эндотелиальная дисфункция, нежелательные эффекты лечения, Pediatrics, RJ1-570, 3. Good health

File Description: application/pdf

Access URL: https://doaj.org/article/970a8774d7544e989eebde17aba1bef2
http://childshealth.zaslavsky.com.ua/article/download/75191/127478
https://doaj.org/article/970a8774d7544e989eebde17aba1bef2
http://childshealth.zaslavsky.com.ua/article/view/75191
http://childshealth.zaslavsky.com.ua/article/view/75191

View record at OpenAIRE Full Text Finder

2

Academic Journal

Rational Use of Medicines in the Provision of Medical Care for Children with Autism Spectrum Disorders

Source: Психиатрия, психотерапия и клиническая психология. :779-790

Subject Terms: 03 medical and health sciences, клинический протокол, 0302 clinical medicine, лекарственные средства, clinical guidelines, autism spectrum disorders, клинические рекомендации, adverse effects, расстройства аутистического спектра, нежелательные эффекты, clinical protocol, drugs, 3. Good health

3

Academic Journal

Safety and tolerability of repetitive transcranial magnetic stimulation: an analysis of over 1200 sessions ; Безопасность и переносимость ритмической транскраниальной магнитной стимуляции: анализ более 1200 сессий

Authors: I. S. Bakulin, A. Kh. Zabirova, A. G. Poydasheva, D. Yu. Lagoda, N. A. Suponeva, M. A. Piradov, И. С. Бакулин, А. Х. Забирова, А. Г. Пойдашева, Д. Ю. Лагода, Н. А. Супонева, М. А. Пирадов

Source: Neurology, Neuropsychiatry, Psychosomatics; Vol 15, No 3 (2023); 35-40 ; Неврология, нейропсихиатрия, психосоматика; Vol 15, No 3 (2023); 35-40 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2023-3

Subject Terms: головная боль, adverse reaction, safety, tolerability, headache, нежелательные эффекты, безопасность, переносимость

File Description: application/pdf

Relation: https://nnp.ima-press.net/nnp/article/view/2027/1533; Burke MJ, Fried PJ, Pascual-Leone A. Transcranial magnetic stimulation: Neurophysiological and clinical applications. Handb Clin Neurol. 2019;163:73-92. doi:10.1016/B978-0-12804281-6.00005-7; Lefaucheur JP, Aleman A, Baeken C, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014–2018). Clin Neurophysiol. 2020 Feb;131(2):474-528. doi:10.1016/j.clinph.2019.11.002; Супонева НА, Бакулин ИС, Пойдашева АГ, Пирадов МА. Безопасность транскраниальной магнитной стимуляции: обзор международных рекомендаций и новые данные. Нервно-мышечные болезни. 2017;7(2):21-36. doi:10.17650/2222-87212017-7-2-21-36; Rossi S, Hallett M, Rossini PM, et al. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009 Dec;120(12):2008-39. doi:10.1016/j.clinph.2009.08.016; Rossi S, Antal A, Bestmann S, et al. Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines. Clin Neurophysiol. 2021 Jan;132(1):269-306. doi:10.1016/j.clinph.2020.10.003; Lerner AJ, Wassermann EM, Tamir DI. Seizures from Transcranial Magnetic Stimulation 2012–2016: Results of a survey of active laboratories and clinics. Clin Neurophysiol. 2019 Aug;130(8):1409-16. doi:10.1016/j.clinph.2019.03.016; Chou YH, Ton That V, Chen AYC, et al. TMS-induced seizure cases stratified by population, stimulation protocol, and stimulation site: A systematic literature search. Clin Neurophysiol. 2020 May;131(5):1019-20. doi:10.1016/j.clinph.2020.02.008; Stultz DJ, Osburn S, Burns T, et al. Transcranial Magnetic Stimulation (TMS) Safety with Respect to Seizures: A Literature Review. Neuropsychiatr Dis Treat. 2020 Dec;16:2989-3000. doi:10.2147/NDT.S276635; Maizey L, Allen CPG, Dervinis M, et al. Comparative incidence rates of mild adverse effects to transcranial magnetic stimulation. Clin Neurophysiol. 2013 Mar;124(3):536-44. doi:10.1016/j.clinph.2012.07.024; Tarapore PE, Picht T, Bulubas L, et al. Safety and tolerability of navigated TMS in healthy volunteers. Clin Neurophysiol. 2016 Mar;127(3):1916-8. doi:10.1016/j.clinph.2015.11.043; Zewdie E, Ciechanski P, Kuo HC, et al. Safety and tolerability of transcranial magnetic and direct current stimulation in children: Prospective single center evidence from 3.5 million stimulations. Brain Stimul. 2020 MayJun;13(3):565-75. doi:10.1016/j.brs.2019.12.025; Zis P, Shafique F, Hadjivassiliou M, et al. Safety, Tolerability, and Nocebo Phenomena During Transcranial Magnetic Stimulation: A Systematic Review and Meta-Analysis of Placebo-Controlled Clinical Trials. Neuromodulation. 2020 Apr;23(3):291-300. doi:10.1111/ner.12946; Berlim MT, Van Den Eynde F, Tovar-Perdomo S, et al. Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: A systematic review and meta-analysis of randomized, double-blind and sham-controlled trials. Psychol Med. 2014 Jan;44(2):22539. doi:10.1017/S0033291713000512; Giustiniani A, Vallesi A, Oliveri M, et al. A questionnaire to collect unintended effects of transcranial magnetic stimulation: A consensus based approach. Clin Neurophysiol. 2022 Sep;141:101-8. doi:10.1016/j.clinph.2022.06.008; Бакулин ИС, Пойдашева АГ, Лагода ДЮ и др. Безопасность и переносимость различных протоколов высокочастотной ритмической транскраниальной магнитной стимуляции. Ульяновский медико-биологический журнал. 2019;(1):26-37. doi:10.34014/22271848-2019-1-26-37; Бакулин ИС, Пойдашева АГ, Забирова АХ и др. ТМС-индуцированная головная боль. Нервные болезни. 2022;(2):5660. doi:10.24412/2226-0757-2022-12826; Newcombe RG. Two-sided confidence intervals for the single proportion: Comparison of seven methods. Stat Med. 1998 Dec;(17):85772. doi:10.1002/(sici)10970258(19980430)17:83.0.co;2-e; Krishnan C, Santos L, Peterson MD, Ehinger M. Safety of noninvasive brain stimulation in children and adolescents. Brain Stimul. 2015 Jan-Feb;8(1):76-87. doi:10.1016/j.brs.2014.10.012; Machii K, Cohen D, Ramos-Estebanez C, Pascual-Leone A. Safety of rTMS to non-motor cortical areas in healthy participants and patients. Clin Neurophysiol. 2006 Feb;117(2):455-71. doi:10.1016/j.clinph.2005.10.014; Teo WP, Kannan A, Loh PK, et al. Poor Tolerance of Motor Cortex rTMS in Chronic Migraine. J Clin Diagn Res. 2014 Sep;8(9):MM01-2. doi:10.7860/JCDR/2014/9377.4886; Conforto AB, Amaro E Jr, Goncalves AL, et al. Randomized, proof-of-principle clinical trial of active transcranial magnetic stimulation in chronic migraine. Cephalalgia. 2014 May;34(6):464-72. doi:10.1177/0333102413515340; Mohamad Safiai NI, Mohamad NA, Basri H, et al. High-frequency repetitive transcranial magnetic stimulation at dorsolateral prefrontal cortex for migraine prevention: A systematic review and meta-analysis. Cephalalgia. 2022 Sep;42(10):1071-85. doi:10.1177/03331024221092423; Zhong J, Lan W, Feng Y, et al. Efficacy of repetitive transcranial magnetic stimulation on chronic migraine: A meta-analysis. Front Neurol. 2022 Nov;13:1050090. doi:10.3389/fneur.2022.1050090

Availability: https://nnp.ima-press.net/nnp/article/view/2027
https://doi.org/10.14412/2074-2711-2023-3-35-40

View record from BASE

4

Academic Journal

Церебральный венозный тромбоз и ишемический инсульт на фоне гормональной контрацепции ; Cerebral venous thrombosis and ischemic stroke with hormonal contraception

Authors: Abusueva, B. A., Abusueva, Z. A., Manysheva, K. B., Alieva, N. A., Azimova, A. A., Абусуева, Б. А., Абусуева, З. А., Манышева, К. Б., Алиева, Н. А., Азимова, А. А.

Subject Terms: WOMEN'S HEALTH, CEREBRAL VENOUS THROMBOSIS, ISCHEMIC STROKE, COMBINED ORAL CONTRACEPTIVES, UNDESIRABLE EFFECTS OF HORMONE THERAPY, REPRODUCTIVE AGE, ЖЕНСКОЕ ЗДОРОВЬЕ, ЦЕРЕБРАЛЬНЫЙ ВЕНОЗНЫЙ ТРОМБОЗ, ИШЕМИЧЕСКИЙ ИНСУЛЬТ, КОМБИНИРОВАННЫЕ ОРАЛЬНЫЕ КОНТРАЦЕПТИВЫ, НЕЖЕЛАТЕЛЬНЫЕ ЭФФЕКТЫ ГОРМОНАЛЬНОЙ ТЕРАПИИ, РЕПРОДУКТИВНЫЙ ВОЗРАСТ

File Description: application/pdf

Relation: Уральский медицинский журнал. 2019. Т. 170, № 2.; http://elib.usma.ru/handle/usma/12538

Availability: http://elib.usma.ru/handle/usma/12538

View record from BASE

5

Academic Journal

Церебральный венозный тромбоз и ишемический инсульт на фоне гормональной контрацепции

Subject Terms: женское здоровье, ишемический инсульт, нежелательные эффекты гормональной терапии, церебральный венозный тромбоз, combined oral contraceptives, undesirable effects of hormone therapy, reproductive age, ischemic stroke, репродуктивный возраст, cerebral venous thrombosis, комбинированные оральные контрацептивы, women's health, 3. Good health

Access URL: https://umj.usma.ru/jour/article/view/479

6

Academic Journal

Осторожно тромбоз! Что важно знать участковому терапевту в отношении пациентов после ортопедических операций ; Thrombosis: a note of caution! What a district therapist important to know about for patients after orthopedic surgery

Authors: Borisova, L. V., Didichenko, S. N., Bezludnaya, N. V., Lyubimov, Е. А., Борисова, Л. В., Дидиченко, С. Н., Безлюдная, Н. В., Любимов, Е. А.

Subject Terms: ENDOPROSTHESIS REPLACEMENT, VENOUS THROMBOEMBOLIC COMPLICATIONS, THROMBOPROPHYLAXIS, NEW ORAL ANTICOAGULANTS, UNDESIRABLE EFFECTS OF ANTICOAGULANTS, ЭНДОПРОТЕЗИРОВАНИЕ, ВЕНОЗНЫЕ ТРОМБОЭМБОЛИЧЕСКИЕ ОСЛОЖНЕНИЯ, ТРОМБОПРОФИЛАКТИКА, НОВЫЕ ОРАЛЬНЫЕ АНТИКОАГУЛЯНТЫ, НЕЖЕЛАТЕЛЬНЫЕ ЭФФЕКТЫ АНТИКОАГУЛЯНТОВ

File Description: application/pdf

Relation: Уральский медицинский журнал. 2017. Т. 147, № 3.; http://elib.usma.ru/handle/usma/13027

Availability: http://elib.usma.ru/handle/usma/13027

View record from BASE

7

Academic Journal

LEVETIRACETAM IN TREATMENT OF EPILEPSY, OWN EXPERIENCE OF APPLICATION IN ADULT PATIENTS ; ЛЕВЕТИРАЦЕТАМ В ЛЕЧЕНИИ ЭПИЛЕПСИИ СОБСТВЕННЫЙ ОПЫТ ПРИМЕНЕНИЯ У ВЗРОСЛЫХ ПАЦИЕНТОВ

Authors: G. G. Toropina, Г. Г. Торопина

Source: Meditsinskiy sovet = Medical Council; № 10 (2017); 60-64 ; Медицинский Совет; № 10 (2017); 60-64 ; 2658-5790 ; 2079-701X ; 10.21518/2079-701X-2017-10

Subject Terms: нежелательные эффекты, idiopathic generalized epilepsy, juvenile myoclonic epilepsy, idiopathic focal epilepsy, symptomatic epilepsy, adult patients, efficacy, adverse effects, идиопатическая генерализованная эпилепсия, юношеская миоклоническая эпилепсия, идиопатическая фокальная эпилепсия, симптоматическая эпилепсия, взрослые пациенты, эффективность

File Description: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/1868/1807; Löscher W, Hönack D. Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats. Eur. J. Pharmacol., 1993, 232: 147-158.; Gower AJ, Hirsch E, Boehrer A, Noyer M, Marescaux C. Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy. Epilepsy Res, 1995, 22: 207-213.; Klitgaard H, Matagne A, Gobert J, Wülfert E. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy. Eur. J. Pharmacol., 1998, 353: 191-206.; Noyer M, Gillard M, Matagne A, Hénichart JP, Wülfert E. The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes. Eur. J. Pharmacol., 1995, 286: 137-146.; Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, Fuks B. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc. Natl. Acad. Sci. USA, 2004, 101: 9861-9866.; Lukyanetz EA, Shkryl VM, Kostyuk PG. Selective blockade of N-type calcium channels by levetiracetam. Epilepsia, 2002, 43: 9-18.; Rigo JM, Hans G, Nguyen L, Rocher V, Belachew S, Malgrange B, Leprince P, Moonen G, Selak I, Matagne A, Klitgaard H. The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABAand glycine-gated currents. Br. J. Pharmacol., 2002, 136: 659-672.; Niespodziany I, Klitgaard H, Margineanu DG. Levetiracetam inhibits the high-voltage-activated Ca(2+) current in pyramidal neurones of rat hippocampal slices. Neurosci. Lett., 2001, 306: 5-8.; Glass GA, Stankiewicz J, Mithoefer A, Freeman R, Bergethon PR. Levetiracetam for seizures after liver transplantation. Neurology, 2005, 64: 1084-1085.; Zaatreh MM. Levetiracetam in porphyric status epilepticus: a case report. Clin. Neuropharmacol., 2005, 28: 243-244.; Brockmöller J, Thomsen T, Wittstock M, Coupez R, Lochs H, Roots I. Pharmacokinetics of levetiracetam in patients with moderate to severe liver cirrhosis (Child-Pugh classes A, B, and C): characterization by dynamic liver function tests. Clin. Pharmacol. Ther., 2005, 77: 529-541.; Зенков Л.Р. Кеппра в лечении эпилепсии. М.: Пресс-сервис, 2007.; Abou-Khalil B.W. Levetiracetam Efficacy in Idiopathic Generalized Epilepsy: Long Suspected and Now Confirmed in Randomized Clinical Trials. Epilepsy Curr., 2008, 8: 16-18.; Verrotti A, Cerminara C, Coppola G, Franzoni E, Parisi P, Iannetti P, Aloisi P, Tozzi E, Cusmai R, Vigevano F, Chiarelli F, Curatolo P. Levetiracetam in juvenile myoclonic epilepsy: long-term efficacy in newly diagnosed adolescents. Dev. Med. Child. Neurol., 2008, 50: 29-32.; Alhamrani М, Babtain F, Bhatia H, Velmurugan M. Comparison of Levetiracetam With Sodium Valproate in Controlling Seizure in Patients Suffering From Juvenile Myoclonic Epilepsy. Jentashapir. J. Health Res, 2014, 5(4): e21875.; Sirven JI, Drazkowski JF. Levetiracetam. Wyllie’s Treatment of Epilepsy: Principles and Practice (5th ed). Eds.: Wyllie E, Cascino GD, Gidal BE, Goodkin HP. Phyladelphia: Lippincott Williams & Wilkins, 2011: 731-735.; Карлов В.А., Власов П.Н., Жидкова И.А. Предварительные результаты эффективности генерического леветирацетама (эпитерра) в тонотерапии эпилепсии у взрослых пациентов. Неврология, нейропсихиатрия, психосоматика, 2015, спецвыпуск 1: 36-40.; Vrielynck P. Current and emerging treatments for absence seizures in young patients. Neuropsychiatr. Dis. Treat., 2013, 9: 963-975.; Trinka E, Dobesberger J. New treatment options in status epilepticus: a critical review on intravenous levetiracetam. Ther. Adv. Neurol. Dis., 2009, 2: 79-91.; Atmaca MM, Orhan EK, Bebek N, Gurses C. Intravenous levetiracetam treatment in status epilepticus: A prospective study. Epilepsy Res, 2015, 114: 13-22.; Grosso S, Cordelli DM, Franzoni E, Coppola G, Capovilla G, Zamponi N, Verrotti A, Morgese G, Balestri P. Efficacy and safety of levetiracetam in infants and young children with refractory epilepsy. Seizure, 2007, 16: 345-350.; Ramantani G, Ikonomidou C, Walter B, Rating D, Dinger J. Levetiracetam: safety and efficacy in neonatal seizures. Eur. J. Paediatr. Neurol., 2011, 15: 1-7.; Mruk AL, Garlitz KL, Leung NR. Levetiracetam in neonatal seizures: A Review. J. Pediatr. Pharmacol. Ther., 2015, 20: 76-89.; Mawhinney E, Craig J, Morrow J, Russell A, Smithson WH, Parsons L, Morrison PJ, Liggan B, Irwin B, Delanty N, Hunt SJ. Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers. Neurology, 2013, 80: 400-405.; Anderson P. Lamotrigine, Levetiracetam top AEDs in pregnancy. American Epilepsy Society (AES) 2016 Annual Meeting. Poster 1.211, December, 2016.; Johannessen SI, Helde G, Brodtkorb E. Levetiracetam concentrations in serum and in breast milk at birth and during lactation. Epilepsia, 2005, 46: 775-777.; Werhahn KJ, Klimpe S, Balkaya S, Trinka E, Krämer G. The safety and efficacy of add-on levetiracetam in elderly patients with focal epilepsy: A one-year observational study. Seizure, 2011, 20: 305-311.

Availability: https://www.med-sovet.pro/jour/article/view/1868
https://doi.org/10.21518/2079-701X-2017-10-60-64

View record from BASE

8

Academic Journal